Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I have a scenario
Better yet, as I posted yesterday, TPL can have MMP and PDS all to themselves for $2B TODAY.  I'd take that in a heartbeat.  Let them assume all the risk and all the reward.  That would give PTSC over $5/shr in cash in the bank, and oodles of opportunity for M&A and moving forward without looking back!
Share
New Message
Please login to post a reply